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Although home care has expanded in scope and intensity in the United States in the past decade,
infection surveillance, prevention, and control efforts have lagged behind. Valid and reliable definitions and
methods for surveillance are needed. Prevention and control efforts are largely based upon acute-care
practices, many of which may be unnecessary, impractical, and expensive in a home setting. Infectious
disease control principles should form the basis of training home-care providers to assess infection risk and
develop prevention strategies.
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Efforts to decrease length of hospital stay and shift care to
ambulatory settings, as well as patient and family preference
to receive care at home, have contributed to the substantial
growth of home care in the past decade. As life expectancy in
the U.S. population continues to increase and patients with
chronic illnesses live longer, home care will continue to
expand.
Home care has also broadened in type and scope in the
past decade. Most patients are elderly and have chronic
conditions requiring skilled nurses and aides. High-tech
home care is provided to patients of all ages and may include
home infusion therapy, tracheotomy care and ventilator
support, dialysis, and other highly invasive procedures. In
addition, home-care nurses provide assessment, education,
and support to post-acute-care patients who might have spent
several additional days in the hospital but are now discharged
to cut costs. This category of patient may include
postoperative patients, postpartum mothers and their
newborns, and patients with acute medical conditions such as
newly diagnosed diabetes and recent strokes.
In the United States, 9,655 agencies (1998 data) (1)
provide home care to patients. Infection control and health-
care epidemiology have not kept up with the needs of the
home-care providers or their patients. As this segment
continues to expand and services provided in the home
increase, the infection control community must address the
risks and needs of home care.
Infection Surveillance, Prevention,
and Control in Home Care
Infection surveillance, prevention, and control have
constituted a discipline that has been acute-care based and
oriented for the past 40 years. However, as the health-care
system continues to shift delivery of care from hospitals to
other settings, surveillance, prevention, and control programs
must respond. Since efforts to measure the incidence of home-
care acquired infections, study the associated risk factors, and
adapt prevention and control measures for home care are
nascent, available studies provide minimal information and
little guidance. A few articles have appeared in non-U.S.
publications. Overall, the literature is sparse, but expanding
slowly (2-22).
Systems of Surveillance:
Definitions and Methods
Without valid data on the incidence of home-care
acquired infection and analysis of risk factors, developing
control efforts is difficult. Thus, initial resources must be
directed toward developing measurement systems. Defini-
tions and methods for the surveillance of nosocomial infection
cannot be readily applied to home care. First, definitions, such
as those developed by the Centers for Disease Control and
Prevention’s (CDC) National Nosocomial Infection Surveil-
lance (NNIS) system (23), rely heavily on laboratory data,
including cultures and serologic tests. In home care, the
diagnosis of infection for clinical purposes is frequently made
on an empiric basis with substantial reliance upon physical
signs and symptoms. In fact, physicians routinely rely on the
assessment skills of home-care nurses and may not see a
patient before making a presumptive diagnosis and writing
prescriptions. The current reimbursement system does not
support the use of cultures and laboratory tests used for
hospitalized patients. For example, cultures are not routinely
obtained to diagnose or confirm infections of the urinary tract,
respiratory tract, or wound or skin sites. Cultures are more
frequently obtained to confirm and appropriately treat
bloodstream infection in patients undergoing home infusion
therapy.
Definitions of home-care acquired infection developed for
surveillance will need to rely more heavily on clinical signs
and symptoms and tests that can be performed by the home-
care nurse at the bedside (e.g., urine dipstick testing). A
scheme that includes probable home-care acquired infection
(i.e., clinical signs and symptoms of pneumonia) as well as
definite home-care acquired infection (i.e., confirmed by chest
X ray and sputum culture) may be considered. Once
developed, definitions must be examined for validity,
sensitivity, and specificity. However, methods to identify
patients at risk and apply the definitions are also critical.
Surveillance methods routinely used in acute care, such
as cultures and other laboratory tests, are not practical in
home care (24) so other sources of information and methods of
screening must be developed. In addition, a system that relies
on a designated person(s) to review medical records and
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Table. Criteria for inclusion in definitions of home-care-acquired infectiona
Site of infection            Clinical data           Laboratory data
Catheter-related UTIb Change in characteristics of Elevated serum leukocytes,
urine, fever, pain evidence of UTI in urinalysis,
evidence of leukocytes in urine
dipstick test, positive urine culture
(>105 CFU of a single organism
per mL urine)
Postoperative pneumonia Change in character of sputum, Elevated serum leukocytes,
decreased breath sounds, sputum Gram-stained smear
increase in rales and rhonchi, with evidence of respiratory
fever, shortness of breath, pain infection, positive sputum culture,
positive chest X ray
Catheter-related bloodstream Fever with chills and rigors, Elevated serum leukocytes, positive
 infection redness, tenderness, or pain at blood culture, positive catheter
insertion site, purulent drainage culture (after catheter removal)
at site
Skin and soft tissue infection Pain, swelling, tenderness at site, Gram-stain smear with leukocytes
inflammation and warmth, and organisms, positive culture,
purulent drainage, fever elevated serum leukocytes
Endometritis in postpartum Uterine tenderness and abdominal Positive Gram-stain smear of
patients pain, purulent vaginal drainage lochia, positive culture of lochia,
 (lochia), foul-smelling lochia, fever remarkably elevated serum
leukocytes
aSource: Rhinehart E, Friedman M. Infection control in home care. Gaithersburg (MD): Aspen Publishing, Inc.;1999 (22).
bUTI = urinary tract infection.
professionals do in hospitals, is impractical in home care
because of the logistics of patients, staff, and medical records.
A more suitable approach is a two-tiered system, which
relies on home-care nurses to identify and report patients
with clinical signs and symptoms of infection and on an
infection control nurse to review evidence and ascribe a
definition (Table). Screening criteria for home-care nurses
would include fever, new antibiotic order, purulent drainage
from a wound, change in color or odor of urine, change in
consistency or color of sputum, respiratory rales and rhonchi,
and increased serum leukocytes. Once made aware of these
patients, a designated nurse can review the evidence (e.g.,
clinical signs and symptoms, available laboratory data,
nursing and physician progress notes) and apply the
definition of home-care acquired infection. This approach
should enhance both sensitivity (more nurses observing and
reporting patients with clinical signs and symptoms of
infection) and specificity (one nurse applying the definition of
infection). The use of a single infection control nurse should
also improve the reliability of data.
What Is Needed
To achieve a system to measure and study the incidence
and risks for home-care acquired infection, infection control
must develop valid definitions for home-care acquired
infection and practical methods for surveillance. These
definitions and methods must be developed through a broad,
national effort that includes participation by home-care
professionals as well as infection control practitioners. These
professionals must take a very practical approach to this
endeavor and may have to forego rigid application of
epidemiologic techniques for a more suitable surveillance
system. The Association for Professionals in Infection Control
and Epidemiology has recently published draft definitions for
surveillance in home care (25). In parallel, home-care
professionals must engage in learning the epidemiologic
principles of surveillance systems (26) and apply or adapt
them as faithfully as possible.
Once consensus is reached on definitions and methods and
we describe the epidemiology of home-care acquired
infections, we can study specific risk factors for infection.
Home-care professionals need the assistance, support, and
practical guidance of infection control professionals. Because
of substantial financial challenges in home care, one nurse is
often responsible for quality improvement, safety, risk
management, and infection control. These professionals can
apply and manage surveillance systems but will need
substantial guidance and support in developing them.
Efforts to initiate surveillance systems do exist. The
Missouri Home Care Alliance began a program in 1997 to
develop definitions and collect data from home-care agencies
in that and other states. With assistance from CDC’s Hospital
Infections Program, the alliance has made progress in
developing a surveillance system and sharing data. The
Florida Hospital Association also sponsored a surveillance
project for hospital-based home-care agencies (6) in which
they studied the incidence of urinary tract infections and
central-line infections. The Arizona Association for Home
Care also described its methods and results in a cooperative
study to measure and compare rates of urinary tract
infections (7). Similar efforts were undertaken in a
collaborative effort to determine device-related rates of
urinary tract and bloodstream infections in California,
Kentucky, and Indiana (8). These studies provide initial
descriptions of incidence of home-care acquired infections.
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of 2.8 per 1,000 catheter days (6) to 4.5 per 1,000 catheter days
(8). Measures of intravenous catheter-related bloodstream
infections range from 1.1 per 1,000 catheter days (8) to 4.2 per
10,000 catheter days (2). Data from these studies must be
interpreted with caution, however, since surveillance in this
area is in its initial stages and definitions and methods are
not uniform. More studies are in progress, and eventually
there will be consensus on such issues.
Prevention and Control of
Home-Care Acquired Infection
Even without reliable surveillance data, we know that
infection prevention and control in home care is quite
different from that in acute care. In acute care, a patient’s risk
for nosocomial infection is related not only to the severity of
illness and exposure to invasive interventions and devices but
also to environmental risks, including exposure to other
patients and inanimate reservoirs of nosocomial pathogens.
The home-care patient may have less clinical “acuity” (i.e.,
intensity or degree of care needed) but may have substantial
host risk factors, including advanced age, chronic illness, or
immunosuppression. Much of home care is provided by family
members in a setting that is much less structured and
controlled than the hospital environment. Plumbing,
sanitation, and ventilation may be poor or absent.
Nonetheless, basic principles of prevention and control can be
adapted and applied with large doses of realistic risk
assessment and common sense.
Because written resources for home-care practice are
lacking, many home-care providers have adopted unnecesssary
infection control practices to reduce risk for patients,
including the ritual of nursing bag technique (i.e., placing a
newspaper under the nursing bag), policies that require the
routine disinfection of noncritical devices (e.g., stethoscopes
and blood pressure cuffs) after every use, and procedures that
require handwashing based on seemingly arbitrary criteria
(e.g., upon entering the home). Some of these practices are not
only unnecessary but also costly (e.g., routine changing of
urinary drainage bags every 30 days).
Patient-care practices to reduce the risk for home-care
acquired infection must be based on the basic science
embodied in the chain of infection model. Actual risk and
appropriate prevention and control strategies must be
incorporated in recommendations for policy and procedure.
Using this simple approach to determine actual risk and
implement the appropriate prevention and control strategies
will lead to more reasonable and less ritualistic practices for
patient care and use of precautions to prevent the spread of
infections to others. Infection control professionals should
approach their responsibility to guide home-care providers by
first addressing educational needs. Knowledge of infection
control principles enables home-care providers to develop
their own approaches to patient care and make decisions
about infection risk and its reduction.
Patient-Care Practices
Infection prevention strategies in home care should focus
on home infusion therapy, urinary tract care, respiratory
care, wound care, and enteral therapy. Most recommended
practices on intravenous therapy (27) do not require
adaptation for the home. However, in care involving other
sites, the risk may be lower, allowing for adaptation of
practices designed for hospitalized patients. For example, use
of indwelling urinary catheters creates an inherent risk for
infection. In the hospital, considerable efforts are exerted to
maintain an intact, closed urinary drainage system (28);
however, in home care the system is frequently interrupted
when an ambulatory patient uses a leg bag. Drainage bags
may also be disinfected in the home, a procedure rarely (if
ever) seen in a hospital. Guidance provided to accomplish this
procedure is empiric (21,22). Similarly, empiric approaches
have been developed for home wound care. Surgical site
infection should rarely, if ever, be a home-care acquired
infection if the wound is primarily closed and no drains are
left in place. However, if a surgical patient is sent home with
drains, a surgical site infection may develop, and wound-care
procedures must address this risk. More frequently, home-
care patients have other types of wounds, such as stasis ulcers
and pressure sores, which are commonly colonized with gram-
negative flora and may become infected with the patient’s own
organisms. Again, procedures for care of these wounds must
be based on the genuine potential for contamination and
infection. Arbitrary instructions to discard irrigation fluids at
set intervals (e.g., every 24 or 48 hours) are not helpful.
Procedures must be practical, with guidance to use containers
of fluid that will be used up in two to three visits (i.e., no more
than a 500-mL bottle) and incorporate methods to avoid
contamination of fluids (e.g., proper handling of the cap,
storage away from children and pets) (22).
Many home-care patients receive enteral therapy,
introducing the risk for gastrointestinal infection. Again, to
reduce this risk, focus must be placed on refrigeration of the
enteral feeding and meticulous care of kitchen appliances and
tools, such as blenders, used in its preparation. Cleaning
blender parts, measuring cups, and spoons in a dishwasher
after use is probably sufficient; sterilizing them is probably
not necessary (22).
Use of Barrier Precautions
The rationale and strategy for use of precautions in home
care differ substantially from those applied in hospitals (29).
In most cases, the use of gowns, gloves, and masks in the care
of homebound patients is recommended to protect the health-
care provider, not the patient. In addition to standard
precautions, care givers in the home may need to use masks
only when caring for patients with pulmonary tuberculosis.
The exception to this rule may be the home-care patient who
is colonized or infected with multidrug-resistant organisms
(16,30). Although these organisms are not known to be a risk
to providers, they may be transmitted to other home-care
patients through inanimate objects or hands. Thus, home-
care patients known to have a multidrug-resistant organism
should be cared for through use of appropriate barriers.
Reusable equipment such as stethoscopes and blood pressure
cuffs should remain in the home. If practical, such patients
should be seen as the last appointment of the day. If this is not
possible, visits should be scheduled to avoid seeing patients at
risk, such as those requiring wound care, after seeing a
patient with multidrug-resistant organisms.
The Future of Infection
Control in Home Care
The next several years will be critical for developing
surveillance systems for home care. Additional studies and
reports are needed to improve knowledge of the risk factors for
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effects of the current empiric practices for preventing such
infections. Hospital-based infection control professionals
must support and guide their home-care colleagues to develop
an evidence-based approach to infection control in home care.
A scientific approach will help identify valid risks and
successful risk-reduction strategies, as well as improve the
quality of care and preserve resources.
Ms. Rhinehart, vice president of quality management for AIG Con-
sultants, Inc., is a full-time health-care consultant. She is one of the
principal authors of the revision of CDC’s Guidelines for Isolation Pre-
cautions in Hospitals (in progress), which will be more applicable to
home-care and other ambulatory-care settings.
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